Progyny Inc (PGNY)

Working capital turnover

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Revenue US$ in thousands 1,091,910 787,727 501,082 344,979 229,624
Total current assets US$ in thousands 640,407 433,856 258,539 190,222 132,444
Total current liabilities US$ in thousands 185,950 159,536 98,824 77,786 36,163
Working capital turnover 2.40 2.87 3.14 3.07 2.38

December 31, 2023 calculation

Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $1,091,910K ÷ ($640,407K – $185,950K)
= 2.40

Progyny Inc's working capital turnover has exhibited fluctuations over the past five years. The company's working capital turnover ratio decreased from 3.13 in 2021 to 2.87 in 2022, before experiencing a further decline to 2.40 in 2023. This downward trend indicates that Progyny is generating less revenue relative to its working capital base in recent years. However, compared to 2019 and 2020, the working capital turnover has remained at a relatively higher level, suggesting that the company has been more efficient in utilizing its working capital to generate sales during the last three years. Further analysis is needed to assess the underlying reasons for these fluctuations and determine the overall implications for Progyny's operational efficiency and financial performance.


Peer comparison

Dec 31, 2023

Company name
Symbol
Working capital turnover
Progyny Inc
PGNY
2.40
DaVita HealthCare Partners Inc
DVA
24.49
Sotera Health Co
SHC
3.21